Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.502 GBX | -1.51% | -4.03% | -34.70% |
04-25 | Hemogenyx Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-29 | Hemogenyx Pharmaceuticals raises money for leukaemia treatment | AN |
Business Summary
Number of employees: 14
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexis Sandler
FOU | Founder | - | 11-12-31 |
Founder | 59 | 11-12-31 | |
Elina Shrestha
CTO | Chief Tech/Sci/R&D Officer | - | - |
Stuart Tinch
PRN | Corporate Officer/Principal | - | 22-08-21 |
Koen van Besien
PRN | Corporate Officer/Principal | - | 22-08-09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Redmond
BRD | Director/Board Member | 76 | 17-10-03 |
Marc Feldmann
CHM | Chairman | 79 | 18-04-08 |
Founder | 59 | 11-12-31 | |
Alexis Sandler
FOU | Founder | - | 11-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,341,815,988 | 1,197,879,870 ( 89.27 %) | 0 | 89.27 % |
Company contact information
HemoGenyx Pharmaceuticals Plc
60 Gracechurch Street 6th Floor
EC3V 0HR, London
+
http://www.hemogenyx.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-34.70% | 25.61M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.68% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- SILF Stock
- Company Hemogenyx Pharmaceuticals Plc